Skip to main content
. 2019 Aug 27;14(8):e0221595. doi: 10.1371/journal.pone.0221595

Fig 2. Compositional variation of major selected erythrocyte PC species between ARDS patients and healthy controls.

Fig 2

Results are shown as both grouped and individual data at baseline and 96 hours for A) PC16:0_18:2, B) PC16:0_18:1, C) 18:0_18:2 and D) 16:0_20:4 and E) total arachidonoyl-containing PC. Panel F details the overall gradual change with time for total arachidonoyl-PC. *P<0.05 comparison between patients and controls. $P<0.05 for comparison between 0 and 96 hours in ARDS patients.